Skip to content

Intraoperative Nanocarbon Versus Methylene blue using in Total Thyroidectomy for Prevention of Postoperative Hypoparathyroidism

Intraoperative Nanocarbon Versus Methylene blue using in Total Thyroidectomy for Prevention of Postoperative Hypoparathyroidism

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
PACTR
Registry ID
PACTR202602760020883
Enrollment
150
Registered
2026-02-10
Start date
2021-10-01
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Surgery

Interventions

traditional thyroidectomy
thyroidectomy with intraoperative utilization of methylene blue spray
thyroidectomy with intraoperative use of carbon nanoparticles

Sponsors

Al Azhar university
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients between 18 and 60 years old penign thyroid disease and failed medical management with the indication for thyroidectomy

Exclusion criteria

Exclusion criteria: patients above 60 years old patients with hypocalcemia or hypoparathyroidism renal impairment major cardiac diseases G6PD deficiency pregnant patients patients unfit for general surgery patients with methylene blue allergies patients having received monoamine oxidase (MAO) inhibitors like isocarboxazid, tranylcypromine, and phenelzine (because methylene blue is a potent inhibitor of MAO and, in combination with serotonergic agents, can produce serotonin toxicity in the perioperative period).

Design outcomes

Primary

MeasureTime frame
The number of parathyroid glands identified and preserved through surgery

Secondary

MeasureTime frame
levels of serum PTH and calcium at postoperative

Countries

Egypt

Contacts

Public ContactAbdelmonem Abdelfattah Mohammed

Assistant professor of surgery Faculty of medicine Al Azhar University Assuit branch Egypt

Monemadam2016@gmail.com00201111106805

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026